Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Items 41-50 of 54

Page
per page
  1. BAW2881 (NVP-BAW2881)
    B7800 BAW2881 (NVP-BAW2881)
    Summary: VEGFR inhibitor
      ≥42.4 mg/mL
  2. SU5416
    A3847 SU5416
    Target: VEGFR
    Summary: VEGF receptor inhibitor and AHR agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  3. Regorafenib hydrochloride
    A3750 Regorafenib hydrochloride
    Target: Raf|VEGFR|PDGFR|c-Kit|c-RET
    Summary: Tyrosine kinase inhibitor
      ≥25.95 mg/mL
  4. Regorafenib monohydrate
    A3751 Regorafenib monohydrate
    Summary: Tyrosine kinase inhibitor
      ≥25.05 mg/mL
  5. TG 100801
    A3870 TG 100801
    Target: VEGFR|FGFR|Src|Fyn kinase
    Summary: Multi-kinase inhibitor
      Soluble in DMSO
  6. Vandetanib hydrochloride
    A3906 Vandetanib hydrochloride
    Summary: VEGFR/EGFR inhibitor
      ≥51.2 mg/mL
  7. DMH4
    B5611 DMH4
     1 Citation
    Summary: VEGFR-2 inhibitor
      <20.02 mg/mL
  8. (E)-FeCP-oxindole
    B5490 (E)-FeCP-oxindole
    Summary: VEGFR-2 inhibitor
      insoluble in DMSO
  9. (Z)-FeCP-oxindole
    B5491 (Z)-FeCP-oxindole
    Summary: VEGFR-2 inhibitor
      insoluble in DMSO
  10. TSU-68 (SU6668,Orantinib)
    A5331 TSU-68 (SU6668,Orantinib)
    Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive
      insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL

Items 41-50 of 54

Page
per page